Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p53 mutations in cyclophosphamide-associated bladder cancer.
Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, Boice JD Jr, Tarone RE, Bennett WP. Khan MA, et al. Among authors: van leeuwen fe. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):397-403. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610789
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R. van Leeuwen FE, et al. Among authors: van den belt dusebout aw. J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7. doi: 10.1093/jnci/87.20.1530. J Natl Cancer Inst. 1995. PMID: 7563187
Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM, et al. Travis LB, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 1994 Oct 5;86(19):1450-7. doi: 10.1093/jnci/86.19.1450. J Natl Cancer Inst. 1994. PMID: 8089863
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R. van Leeuwen FE, et al. Among authors: van den belt dusebout aw, van kerkhoff eh. J Clin Oncol. 1994 May;12(5):1063-73. doi: 10.1200/JCO.1994.12.5.1063. J Clin Oncol. 1994. PMID: 8164031
Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, et al. Travis LB, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 1993 Dec 1;85(23):1932-7. doi: 10.1093/jnci/85.23.1932. J Natl Cancer Inst. 1993. PMID: 8230284
Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF Jr, Boice JD Jr. Travis LB, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 1997 Oct 1;89(19):1429-39. doi: 10.1093/jnci/89.19.1429. J Natl Cancer Inst. 1997. PMID: 9326912
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB. Metayer C, et al. Among authors: van t veer mb, van leeuwen fe. J Clin Oncol. 2000 Jun;18(12):2435-43. doi: 10.1200/JCO.2000.18.12.2435. J Clin Oncol. 2000. PMID: 10856104
493 results